CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 124 enrolled
Drug / intervention
Pantoprazole 40 mg IV daily and tube feed. +1 moredrug
Likely dose
Pantoprazole 40 mg IV daily and tube feed.from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01477320
NCT01477320N/ACompleted

Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Prospective, Double-blind, Randomized, Placebo-controlled Study.

Mohamed Saad·interventional·Posted Nov 22, 2011·Updated Jan 16, 2018

In Brief

A clinical study evaluating Pantoprazole 40 mg IV daily and tube feed. and Placebo and tube feed for Gastrointestinal Hemorrhage and Clostridium Difficile Colitis. Completed, enrolled 124 participants across 1 site.

Detailed Summary

study is to determine if proton pump inhibitors plus enteral nutrition is superior to enteral nutrition alone as a stress ulcer prophylaxis strategy in critically ill patients in terms of incidence of overt and significant GI bleeding related to stress gastropathy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 22, 2011
Enrollment StartSep 1, 2013
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 14.6 years ago

Interventions

Pantoprazole 40 mg IV daily and tube feed.drug

Patients randomized to the control group "active Comparator" will receive tube feed plus an Pantoprazole 40 mg IV daily.

Placebo and tube feedother

Patients randomized to Placebo group "placebo Comparator" will receive tube feed plus an Placebo.